Peter Michael Mowschenson, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proctocolectomy, Restorative | 5 | 2019 | 190 | 0.620 |
Why?
|
Ileostomy | 4 | 2017 | 120 | 0.330 |
Why?
|
Thyroidectomy | 5 | 2021 | 902 | 0.310 |
Why?
|
Thyroid Neoplasms | 5 | 2021 | 2332 | 0.300 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2021 | 325 | 0.250 |
Why?
|
Hyperparathyroidism | 4 | 2011 | 337 | 0.240 |
Why?
|
Rectum | 2 | 2019 | 895 | 0.220 |
Why?
|
Ambulatory Surgical Procedures | 4 | 1999 | 465 | 0.220 |
Why?
|
Parathyroidectomy | 4 | 2011 | 241 | 0.220 |
Why?
|
Colitis, Ulcerative | 5 | 2019 | 1919 | 0.190 |
Why?
|
Cholecystectomy, Laparoscopic | 2 | 1993 | 231 | 0.180 |
Why?
|
Carcinoma | 3 | 2021 | 2330 | 0.180 |
Why?
|
Colonic Pouches | 2 | 2019 | 122 | 0.180 |
Why?
|
Technetium Tc 99m Sestamibi | 3 | 2013 | 173 | 0.170 |
Why?
|
Dysphonia | 1 | 2021 | 144 | 0.160 |
Why?
|
Parathyroid Neoplasms | 2 | 2011 | 241 | 0.160 |
Why?
|
Thyroid Gland | 2 | 1995 | 1168 | 0.150 |
Why?
|
Adenoma | 3 | 2016 | 2148 | 0.130 |
Why?
|
Fecal Incontinence | 2 | 2019 | 241 | 0.120 |
Why?
|
Thyroid Nodule | 1 | 2021 | 760 | 0.110 |
Why?
|
Parathyroid Glands | 1 | 1995 | 517 | 0.110 |
Why?
|
Parathyroid Hormone | 2 | 2011 | 1797 | 0.110 |
Why?
|
Surgical Stapling | 3 | 2017 | 98 | 0.110 |
Why?
|
Prospective Payment System | 2 | 1990 | 136 | 0.100 |
Why?
|
Urinary Catheterization | 1 | 1992 | 198 | 0.100 |
Why?
|
Diagnosis-Related Groups | 2 | 1990 | 449 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1936 | 0.090 |
Why?
|
Rate Setting and Review | 1 | 1990 | 41 | 0.090 |
Why?
|
Postoperative Complications | 6 | 2021 | 15637 | 0.090 |
Why?
|
Surgicenters | 1 | 1990 | 45 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 1066 | 0.080 |
Why?
|
Health Expenditures | 1 | 2021 | 2347 | 0.080 |
Why?
|
Laparoscopy | 2 | 2017 | 2147 | 0.080 |
Why?
|
Adipose Tissue, Brown | 1 | 2013 | 755 | 0.070 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2000 | 218 | 0.060 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2010 | 733 | 0.060 |
Why?
|
Diagnostic Errors | 2 | 2007 | 1263 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2004 | 0.060 |
Why?
|
Preoperative Care | 1 | 1992 | 2249 | 0.050 |
Why?
|
Biopsy, Fine-Needle | 2 | 2021 | 1110 | 0.050 |
Why?
|
Esophagogastric Junction | 1 | 1982 | 341 | 0.040 |
Why?
|
Voice Quality | 1 | 2021 | 226 | 0.040 |
Why?
|
Hypercalcemia | 1 | 1982 | 421 | 0.040 |
Why?
|
Adult | 15 | 2021 | 219935 | 0.040 |
Why?
|
Defecation | 1 | 2019 | 190 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2010 | 2740 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6457 | 0.040 |
Why?
|
Carcinoma, Papillary | 2 | 2016 | 785 | 0.030 |
Why?
|
Urinary Bladder | 2 | 1992 | 1166 | 0.030 |
Why?
|
Aged | 11 | 2021 | 168218 | 0.030 |
Why?
|
Parathyroid Diseases | 1 | 1995 | 46 | 0.030 |
Why?
|
Middle Aged | 12 | 2021 | 219568 | 0.030 |
Why?
|
Cholangiography | 2 | 1993 | 181 | 0.030 |
Why?
|
Humans | 27 | 2021 | 758406 | 0.030 |
Why?
|
Medicare | 2 | 1990 | 6741 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2019 | 64378 | 0.030 |
Why?
|
Employment | 1 | 2021 | 1112 | 0.030 |
Why?
|
Splenectomy | 1 | 1996 | 391 | 0.030 |
Why?
|
Male | 14 | 2021 | 358747 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2017 | 983 | 0.030 |
Why?
|
Hospital Costs | 2 | 1999 | 960 | 0.030 |
Why?
|
Blood Circulation | 1 | 2013 | 249 | 0.030 |
Why?
|
Thyroid Diseases | 1 | 1995 | 386 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 80168 | 0.020 |
Why?
|
Reoperation | 2 | 2009 | 4282 | 0.020 |
Why?
|
Female | 13 | 2021 | 390323 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 2009 | 1975 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4064 | 0.020 |
Why?
|
Urine | 1 | 1992 | 363 | 0.020 |
Why?
|
Ascites | 1 | 1992 | 338 | 0.020 |
Why?
|
Crohn Disease | 1 | 2003 | 2275 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20500 | 0.020 |
Why?
|
Common Bile Duct | 1 | 1990 | 106 | 0.020 |
Why?
|
Fee Schedules | 1 | 1990 | 85 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3714 | 0.020 |
Why?
|
Quality of Life | 2 | 2021 | 13285 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1994 | 1630 | 0.020 |
Why?
|
Biological Transport | 1 | 2013 | 2084 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2495 | 0.020 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 161 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58683 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2009 | 512 | 0.020 |
Why?
|
Neck Dissection | 1 | 2009 | 201 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2009 | 341 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 1628 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39059 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2007 | 115 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12951 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13276 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2021 | 4455 | 0.020 |
Why?
|
Postpartum Period | 1 | 1992 | 1167 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1992 | 1184 | 0.020 |
Why?
|
Feasibility Studies | 1 | 1995 | 5199 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 1999 | 5484 | 0.020 |
Why?
|
Catheterization | 1 | 1990 | 1426 | 0.020 |
Why?
|
Adolescent | 3 | 2016 | 87892 | 0.010 |
Why?
|
Calcium | 2 | 2011 | 5721 | 0.010 |
Why?
|
Cesarean Section | 1 | 1992 | 1385 | 0.010 |
Why?
|
Prospective Studies | 3 | 2011 | 54137 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15785 | 0.010 |
Why?
|
Radiography, Interventional | 1 | 2010 | 1112 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9304 | 0.010 |
Why?
|
United States | 3 | 2021 | 72136 | 0.010 |
Why?
|
Time Factors | 2 | 2021 | 39872 | 0.010 |
Why?
|
Heartburn | 1 | 1982 | 67 | 0.010 |
Why?
|
Glucose | 1 | 2013 | 4336 | 0.010 |
Why?
|
Data Collection | 1 | 1990 | 3322 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25956 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2634 | 0.010 |
Why?
|
Manometry | 1 | 1982 | 453 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 153 | 0.010 |
Why?
|
Pressure | 1 | 1982 | 1155 | 0.010 |
Why?
|
Fibrinopeptide A | 1 | 1978 | 43 | 0.010 |
Why?
|
Biopsy | 1 | 1990 | 6768 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1978 | 143 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21272 | 0.010 |
Why?
|
Hospitals | 1 | 1990 | 3887 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5952 | 0.010 |
Why?
|
Spherocytosis, Hereditary | 1 | 1996 | 84 | 0.010 |
Why?
|
Fibrinogen | 1 | 1978 | 883 | 0.010 |
Why?
|
Platelet Activation | 1 | 1978 | 645 | 0.010 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 1996 | 241 | 0.010 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1990 | 120 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58808 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 1999 | 3446 | 0.000 |
Why?
|
Mice | 1 | 2013 | 81101 | 0.000 |
Why?
|
Thrombosis | 1 | 1978 | 2929 | 0.000 |
Why?
|
Length of Stay | 1 | 1996 | 6439 | 0.000 |
Why?
|
Animals | 1 | 2013 | 167768 | 0.000 |
Why?
|
Recurrence | 1 | 1990 | 8426 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1978 | 866 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1990 | 6313 | 0.000 |
Why?
|
Cardiopulmonary Bypass | 1 | 1978 | 1093 | 0.000 |
Why?
|